Tag: #TakeoverTuesday

The world's largest pharmaceutical company, Pfizer, hosts #TakeoverTuesday.

#TakeoverTuesday with Pfizer

Oct 30, 2019

As the world’s largest pharmaceutical company, Pfizer has long been a household name. But did you know that one of its top global R&D hubs is located right here in San Diego? Pfizer La Jolla is uniquely dedicated to bringing new and meaningful therapies to people living with cancer. Its 500-person San Diego team is […]

Continue Reading
0 Comments

Public outreach and community engagement consulting firm Katz & Associates hosts #TakeoverTuesday

#TakeoverTuesday with Katz & Associates

Oct 24, 2019

Centrally located in Mission Valley, outreach and community engagement firm Katz & Associates combines creativity and passion to improve local communities. Its team of creatives supports companies tackling challenges in water supply, energy, transportation, and other public good projects – all to make San Diego a better place to live. The latest #TakeoverTuesday takes us […]

Continue Reading
0 Comments

The team at Dylan Welch Media works with Spotify, Google Play, and Amazon Prime to boost San Diego media to global audiences.

#TakeoverTuesday with Dylan Welch Media

Oct 17, 2019

Four years ago, Dylan Welch lived in upstate New York, dreaming of a beachside city where he could impact the media industry. In search of a change of scenery, he booked a one-way ticket to San Diego, where he has since produced more than 1,000 television episodes with ABC, NBC, and Amazon Prime, and currently […]

Continue Reading
0 Comments

Health and DNA research platform LunaDNA hosts #TakeoverTuesday.

#TakeoverTuesday with LunaDNA

Aug 14, 2019

Located in La Jolla, a popular hub for biotech companies in San Diego, LunaDNA is the world’s first health and DNA research platform owned by its community of individual contributors. By empowering individuals to securely and privately share their health and DNA data, LunaDNA is helping improve the quality of data and thus, implementing smarter […]

Continue Reading
0 Comments